Our cytometry by time-of-flight analysis shows that CD73 inhibition combined with PD-1 blockade promoted the intra-tumoral infiltration of CD8+ T, CD4+ T cells and NK cells and simultaneously decreased the proportion of macrophages and neutrophils, suggesting that the combination therapy effectively activates anti-tumor immune response in iCCA. This evidence concerns the gene PDCD1 and neoplasm.